Formulation and Pharmacokinetic Evaluation of Microcapsules Containing Pravastatin Sodium Using Rats

Table 8

Dissolution data of formulation f6 after stability studies.

Time (h)	Initial	After 3 months	After 6 months
		30 ± 2^˚C/65 ± 5% RH	30 ± 2^˚C/65 ± 5% RH
	% CDR	% CDR	% CDR
1	24.6 ± 0.1	23.2 ± 0.3	22.0 ± 0.6
2	39.1 ± 0.9	38.7 ± 0.5	38.1 ± 0.1
3	45.0 ± 1.0	43.0 ± 0.1	42.8 ± 0.5
4	50.0 ± 0.1	49.8 ± 0.5	49.1 ± 0.7
5	51.8 ± 0.5	50.1 ± 0.2	49.0 ± 0.8
6	54.9 ± 0.4	54.0 ± 0.3	53.9 ± 0.7
7	69.3 ± 0.3	68.9 ± 0.7	68.0 ± 0.4
8	75.0 ± 0.2	74.9 ± 0.8	74.8 ± 0.3